Primary Health Properties (LON:PHP) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?

Key Points

• Primary Health Properties shares rose above their 200-day moving average, reaching GBX 96.15 versus the GBX 95.73 average, with trading volume exceeding 12.6 million shares.
• Analysts remain generally positive: four rate the stock a Buy and one a Hold, giving PHP a “Moderate Buy” consensus and an average price target of GBX 112.60.
• Insiders have recently shown confidence by purchasing 249,681 shares worth approximately $23.1 million over the past 90 days, while the company maintains a 30-year record of dividend growth.

Primary Health Properties Plc (LON:PHP - Get Free Report) shares crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of GBX 95.73 and traded as high as GBX 96.15. Primary Health Properties shares last traded at GBX 96.15, with a volume of 12,632,944 shares changing hands.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on PHP. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 115 target price on shares of Primary Health Properties in a report on Friday, July 31st. Shore Capital Group reiterated a "house stock" rating on shares of Primary Health Properties in a research report on Thursday, July 30th. Jefferies Financial Group reissued a "buy" rating and set a GBX 107 price target on shares of Primary Health Properties in a research note on Wednesday, October 28th. Finally, Berenberg Bank cut their price target on Primary Health Properties from GBX 133 to GBX 131 and set a "buy" rating for the company in a report on Monday, October 26th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Primary Health Properties currently has an average rating of "Moderate Buy" and a consensus target price of GBX 112.60.

Primary Health Properties Price Performance

The company has a market cap of £2.50 billion, a P/E ratio of 16.03, a PEG ratio of 5.64 and a beta of 0.79. The firm's 50-day moving average is GBX 92.49 and its two-hundred day moving average is GBX 95.73. The company has a debt-to-equity ratio of 131.37, a current ratio of 0.88 and a quick ratio of 0.62.

Primary Health Properties (LON:PHP - Get Free Report) last released its quarterly earnings data on Thursday, October 15th. The real estate investment trust reported GBX (0.14) EPS for the quarter. Primary Health Properties had a net margin of 43.30% and a return on equity of 6.20%. Analysts anticipate that Primary Health Properties Plc will post 7.09 earnings per share for the current year.

Insider Transactions at Primary Health Properties

In other Primary Health Properties news, insider Richard Howell bought 53,504 shares of the firm's stock in a transaction dated Wednesday, October 28th. The shares were purchased at an average cost of GBX 93 per share, for a total transaction of £49,758.72. Also, insider Mark Davies bought 140,759 shares of the firm's stock in a transaction dated Tuesday, October 27th. The shares were acquired at an average price of GBX 93 per share, for a total transaction of £130,905.87. Over the last 90 days, insiders bought 249,681 shares of company stock worth $23,109,497. Insiders own 1.05% of the company's stock.

Primary Health Properties Company Profile

PHP is a leading investor in critical healthcare infrastructure in the UK and Ireland. The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP has an unbroken 30 year track record of dividend growth. To achieve this, PHP invests in healthcare real estate let on long-term leases, backed by secure underlying covenants where the majority of rental income is funded directly or indirectly by a government body.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.